Breakthroughs in Alzheimer’s research may be game-changers - The Philadelphia Inquirer

Research on Alzheimers disease is approaching a much-needed tipping point. The media spotlight has been on newly available drugs like lecanemab and donanemab that target the protein plaques associate… [+5446 chars]